source
- FDA extends review of Capricor cell therapy; Pain drug startup to go publicThe agency is now reviewing an updated application for deramiocel with a “refined” indication. Elsewhere, a startup co-founded by Vivek Ramaswamy is taking a speedy path to the public markets.BioPharma Dive · 2h ago↗ source
- Qiagen appoints new chief executive after 9-month searchMolecular diagnostics specialist Qiagen has a new CEO as Jonathan M. Pratt takes the reins.Fierce Biotech · 7h ago↗ source
- FDA alerts recall of Medline neonatal heated wire breathing circuits over connector failuresThe FDA's Center for Devices and Radiological Health issued an Early Alert to warn the public about a high‑risk issue with Medline's neonatal and infant heated wire breathing circuits. The problem…